Search Results 421-430 of 17868 for monoclonal antibody

1. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Prior chemotherapy, immunotherapy, radioactive, or biological cancer therapy (including monoclonal antibody [mAb]) within 28 days prior to registration.

2. Publications - Leigh L. Speicher, M.D., M.P.H. - Mayo Clinic

   ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Wert K, Donaldson AM, Dinh TA ...

3. Hematology - Clinical trials

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer ... Monoclonal B Cell Lymphocytosis (MBL) and B-Chronic Lymphocytic Leukemia ...

4. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   ... Antibody-Associated Disease (Meteoroid). Print details. Share; Facebook ... Anti-B-lymphocyte stimulator monoclonal antibody (e.g., belimumab) at any time.

5. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

   Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy).

6. Infliximab-qbtx (intravenous route) - Side effects & uses - Mayo Clinic

   Infliximab-qbtx is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

7. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

8. Clinical trials - Oncology (Medical)

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

9. Linvoseltamab-gcpt (intravenous route) - Side effects & uses - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

10. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...